Robert E. Hoffman
Equibles does not estimate personal net worth.
About Robert E. Hoffman
Robert E. Hoffman is recorded as CEO at CytoDyn Inc. (CYDY) since October 20, 2026 and CFO at CytoDyn Inc. (CYDY). The newest filing on record that lists Robert E. Hoffman as CFO at CytoDyn Inc. (CYDY) is dated September 28, 2026. CytoDyn Inc. reported in an 8-K filed October 19, 2026 that Robert E. Hoffman was appointed Chief Executive Officer, effective October 20, 2026. CytoDyn Inc. reported in an 8-K filed May 6, 2025 that Robert E. Hoffman was appointed Chief Financial Officer, effective May 15, 2025. The proxy statement of CytoDyn Inc. reports total compensation of $1,899,609 for Robert E. Hoffman in fiscal 2026, including a base salary of $450,000. Disclosed compensation is on record for 2 fiscal years. CytoDyn Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytoDyn Inc. includes Dr. Jacob P. Lalezari (CEO), Jacob P. Lalezari (CEO), Jacob P. Lalezari, M.D. (CEO) and 7 others.
“On October 16, 2026, at a meeting held by the Board of Directors (the “Board”) of CytoDyn Inc. (the “Company”), which followed a number of discussions among members of the Board’s Nominating and Corporate Governance Committee and Jacob P. Lalezari, M.D. (“Dr. Lalezari”), the Company’s Chief Executive Officer, the Board appointed Robert E. Hoffman (“Mr. Hoffman”) as the Company’s Chief Executive Officer effective October 20, 2026.”
“On May 2, 2025, the Company entered into an agreement with Robert E. Hoffman ("Mr. Hoffman"), under which Mr. Hoffman will serve as the Company's Chief Financial Officer ("CFO"), effective May 15, 2025 (the "Employment Agreement").”
Affiliation history
-
Current
2026-10-20–present
-
Current
Start not stated–present
Last confirmed September 28, 2026
Company network
Leadership on record at CytoDyn Inc.
- Dr. Jacob P. Lalezari CEO
- Jacob P. Lalezari CEO
- Jacob P. Lalezari, M.D. CEO
- Tanya Durkee Urbach Chairman
- Mitchell Cohen CFO, Chief Accounting Officer
- Dr. Christopher P. Recknor, M.D. COO
- Arian Colachis General Counsel
- Alan P. Timmins Board Member
- Gordon A. Gardiner Board Member
- Jordon G. Naydenov Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | CytoDyn Inc. (CYDY) | Chief Financial Officer | $450,000 | $1,899,609 |
| 2025 | CytoDyn Inc. (CYDY) | Chief Financial Officer | $20,000 | $388,526 |